There is information on Recurrent Miscarriage and when to refer in CKS.
These guidelines suggest referral to investigate the cause of recurrent miscarriage for all women who have had:
If a patient who has had recurrent miscarriage becomes pregnant, then consider the following options for advice about the pregnancy:
Reassurance scans are available at NBT for patients who have been seen in the recurrent miscarriage service. Unfortunately, patients who have fallen pregnant whilst awaiting their first appointment are unable to access these scans. If necessary, please discuss referral with the Ultrasound Department at the hospital where they will be booked for their pregnancy:
Scans for reassurance after previous miscarriage or for dating purposes should not be referred to the Early Pregnacy Clinic (EPAC). Patients should only be referred to the Early Pregnany Clinic if they develop symptoms of a possible miscarriage or ectopic.
Investigations
Suggested investigations prior to referral include:
These tests are not mandatory prior to referral but if done will help to streamline the process for patients.
Please note that thrombophilia screen is not required: As part of NHSE reorganization of Genetics Testing from 1st October 2020 patients with primary infertility/recurrent pregnancy loss or other related obstetric conditions are not eligible for centrally funded Prothrombin Gene Mutation or Factor V Leiden analysis on the grounds of poor clinical utility of these assays in this patient group. These assays will not be processed. Please contact haemseniorbms@nbt.nhs.uk to discuss if concerned.
Advice and Guidance
Gynaecology Advice and Guidance is available via eRS if you are unsure if referral is indicated or need specific advice.
NBT and UHB both have clinics where patients with recurrent miscarriage can be referred via eRS.
Fertility Referrals
Referral to NHS fertility clinic for patients with recurrent miscarriage is not usually appropriate and referrals will be returned unless criteria are met. See the Infertility page for details.
Patient Information:
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.